Trial NCT02530502

View at ClinicalTrials.gov 
Org. Study IDs: NU 15C01
Secondary IDs: NCI-2015-00736 NU 15C01 P30CA060553 STU00200883

Last trial update was posted on 2023-11-18

MeSH Interventions

Pembrolizumab Temozolomide

MeSH Conditions

Glioblastoma

Other Conditions

Adult Glioblastoma

Stopping Reasons

The protocol was amendment to be stopped after phase I (phase 2 removed from protocol)

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID